Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |